You are currently viewing a beta version of our website. If you spot anything unusual, kindly let us know.

Preprint
Review

COVID-19: Considerations for Children and Adolescents with Diabetes

Altmetrics

Downloads

888

Views

928

Comments

1

A peer-reviewed article of this preprint also exists.

This version is not peer-reviewed

Submitted:

14 May 2020

Posted:

15 May 2020

You are already at the latest version

Alerts
Abstract
Recent reports suggest that the clinical course of coronavirus disease 2019 (COVID-19) in previously healthy children is usually milder as compared to adults. However, children with comorbid conditions such as diabetes are at increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as well as morbidity and mortality due to COVID-19. Experience in adults with diabetes shows that they are prone to faster metabolic decompensation, develop diabetes-related complications, and have a poor prognosis when hospitalized with COVID-19. Data on children are limited. The aim of this mini-review is to discuss the possible risks to children and adolescents with diabetes during the current pandemic and the special considerations in management in those affected with COVID-19. The challenges for children who develop new-onset type 1 diabetes during the COVID-19 lockdown, especially in accessing healthcare, are also discussed.
Keywords: 
Subject: Medicine and Pharmacology  -   Pediatrics, Perinatology and Child Health
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2024 MDPI (Basel, Switzerland) unless otherwise stated